Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet’s disease: a case series
Antonio Vitale, Donato Rigante, Francesco Caso, Maria Giuseppina Brizi, Mauro Galeazzi, Luisa Costa, Rossella Franceschini, Orso Maria Lucherini, Luca Cantarini
Entra nei temi di ricerca di 'Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet’s disease: a case series'. Insieme formano una fingerprint unica.